PepsiCo (PEP) Q1 2026 Earnings Call Transcript

PepsiCo reported 2.6% organic revenue growth, 9% core EPS growth, and roughly 10 bps of core operating margin expansion, while reaffirming full-year organic revenue guidance of 2%-4%. PFNA showed improving momentum with 2% volume growth, 4% unit growth, and 300 million new consumption occasions, while PBNA grew 9% on organic gains plus recent integrations. Management said inflation remains a key uncertainty, but hedging, productivity programs, and innovation are helping offset volatility and support the outlook.

Analysis

The setup is more constructive for PEP than the headline guide suggests because management is now pulling two levers at once: reclaiming unit growth in North America snacks while still protecting margin through productivity. The important second-order effect is that lower cost per unit is expanding Pepsi’s optionality to be more aggressive on value architecture without immediately sacrificing earnings, which should pressure smaller regional snack players and private label more than direct CPG peers with similar scale. In beverages, the inorganic contribution masks a cleaner inflection in the core mix toward higher-growth functional hydration and energy, which improves the long-run quality of sales even if reported growth looks noisy for a few quarters.

The market may be underestimating how much of this is an operating-model story rather than a pure demand story. Distribution resets, ACV expansion, and household reactivation usually have a lagged payoff that extends into the summer, so the next two quarters should still show improving run-rate even if input inflation turns on. That said, the CFO’s commentary implies the upside is being reserved for defense: if inflation accelerates faster than hedges roll off, the company can lean harder on price pack architecture, but that also raises the probability of category-wide promotional intensity and share volatility.

The main contrarian risk is that consensus extrapolates the quarter into a straight-line recovery. PFNA’s share gains and volume inflection look real, but they are occurring against a backdrop of heavy execution, which means the tougher test is repeat rate after resets normalize and competitors respond into the summer peak. International is a cleaner positive because supply-chain resilience may actually convert geopolitical disruption into a relative advantage, but that benefit is fragile if conflict-related logistics or freight costs broaden beyond current assumptions.

Key Decisions for Investors

• Long PEP vs short MDLZ for 1-2 quarters: PEP has a clearer near-term volume/margin inflection and a stronger productivity-driven offset to inflation; MDLZ lacks the same visible U.S. operating leverage. Target ~8-12% relative outperformance if snack execution holds into summer.
• Buy PEP common on dips rather than chasing strength; use a 30-60 day horizon to capture continued improvement into Q2/Q3 when planogram resets and ACV gains should compound. Risk/reward is favorable if the stock de-rates on inflation headlines while the underlying run-rate keeps improving.
• Pair trade long PEP / short CPB: Pepsi’s snack turnaround is gaining share and occasions, while CPB is more exposed to weaker category elasticity and less diversified margin levers. This is a cleaner relative-value expression of snack recovery than outright beta.
• For higher-conviction event-driven exposure, sell PEP puts 2-3 months out at strikes ~5-8% below spot to get paid for the inflation overhang while keeping upside to the summer volume acceleration. This works only if you are comfortable owning the name on a volatility spike.
• Monitor CELH and other functional hydration peers as a secondary long-basket beneficiary, but prefer PEP over pure-play names: Pepsi controls distribution and can monetize category growth regardless of which brand wins shelf space.